| [1] |
Kaski JC, Crea F, Gersh BJ, et al. Reappraisal of ischemic heart disease[J]. Circulation, 2018, 138(14):1463-1480.
|
| [2] |
Sucato V, Testa G, Puglisi S, et al. Myocardial infarction with non-obstructive coronary arteries (MINOCA): intracoronary imaging-based diagnosis and management[J]. J Cardiol, 2021, 77(5):444-451.
|
| [3] |
Lindahl B, Baron T, Albertucci M, et al. Myocardial infarction with non-obstructive coronary artery disease[J]. EuroIntervention, 2021, 17(11):e875-e887.
|
| [4] |
Padro T, Manfrini O, Bugiardini R, et al. ESC Working Group on coronary pathophysiology and microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'[J]. Cardiovasc Res, 2020, 116(4):741-755.
|
| [5] |
Ford TJ, Stanley B, Good R, et al. Stratified medical therapy using invasive coronary function testing in angina: The CorMicA Trial[J]. J Am Coll Cardiol, 2018, 72(23 Pt A):2841-2855.
|
| [6] |
Tamis-Holland JE, Jneid H, Reynolds HR, et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association[J]. Circulation, 2019, 139(18): e891-e908.
|
| [7] |
Dhoot A, Liu S, Savu A, et al. Cardiac stress testing after coronary revascularization[J]. Am J Cardiol, 2020, 136:9-14.
|
| [8] |
Rush CJ, Berry C, Oldroyd KG, et al. Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction[J]. JAMA Cardiol, 2021, 6(10):1130-1143.
|
| [9] |
Vancheri F, Longo G, Vancheri S, et al. Coronary microvascular dysfunction[J]. J Clin Med, 2020, 9(9):2880.
|
| [10] |
Godo S, Suda A, Takahashi J, et al. Coronary microvascular dysfunction[J]. Arterioscler Thromb Vasc Biol, 2021, 41(5):1625-1637.
|
| [11] |
Liu M, Lovern C, Lycett K, et al. The association between markers of inflammation and retinal microvascular parameters: a systematic review and meta-analysis[J]. Atherosclerosis, 2021, 336:12-22.
|
| [12] |
Tona F, Montisci R, Iop L, et al. Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction[J]. Rev Cardiovasc Med, 2021, 22(1):97-104.
|
| [13] |
Reynolds HR, Picard MH, Spertus JA, et al. Natural history of patients with ischemia and no obstructive coronary artery disease: The CIAO-ISCHEMIA Study[J]. Circulation, 2021, 144(13):1008-1023.
|
| [14] |
Abdu FA, Mohammed AQ, Liu L, et al. Myocardial infarction with nonobstructive coronary arteries (MINOCA): a review of the current position[J]. Cardiology, 2020, 145(9):543-552.
|
| [15] |
Hubert A, Seitz A, Pereyra VM, et al. Coronary artery spasm: the interplay between endothelial dysfunction and vascular smooth muscle cell hyperreactivity[J]. Eur Cardiol, 2020, 15:e12.
|
| [16] |
Pirozzolo G, Seitz A, Athanasiadis A, et al. Microvascular spasm in non-ST-segment elevation myocardial infarction without culprit lesion (MINOCA)[J]. Clin Res Cardiol, 2020, 109(2):246-254.
|
| [17] |
Bechsgaard DF, Prescott E. Coronary microvascular dysfunction: a practical approach to diagnosis and management[J]. Curr Atheroscler Rep. 2021, 23(9):54.
|
| [18] |
Godo S, Takahashi J, Yasuda S, et al. Endothelium in coronary macrovascular and microvascular diseases[J]. J Cardiovasc Pharmacol, 2021, 78(Suppl 6):S19-S29.
|
| [19] |
Bairey Merz CN, Pepine CJ, Walsh MN, et al. Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade[J]. Circulation, 2017, 135(11):1075-1092.
|
| [20] |
Del Buono MG, Montone RA, Camilli M, et al. Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC State-of-the-Art Review[J]. J Am Coll Cardiol, 2021, 78(13):1352-1371.
|
| [21] |
van Diemen PA, Driessen RS, Stuijfzand WJ, et al. Impact of scan quality on the diagnostic performance of CCTA, SPECT, and PET for diagnosing myocardial ischemia defined by fractional flow reserve[J]. J Cardiovasc Comput Tomogr, 2020, 14(1):60-67.
|
| [22] |
Marzilli M, Crea F, Morrone D, et al. Myocardial ischemia: From disease to syndrome[J]. Int J Cardiol, 2020, 314:32-35.
|
| [23] |
Padro T, Manfrini O, Bugiardini R, et al. ESC Working Group on coronary pathophysiology and microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'[J]. Cardiovasc Res, 2020, 116(4):741-755.
|
| [24] |
Camici PG, Crea F, Ferrari R. Commentary: The new ESC guidelines for the diagnosis and management of chronic coronary syndromes[J]. Int J Cardiol, 2019, 297:19-21.
|
| [25] |
Ferrari R, Camici PG, Crea F, et al. Expert consensus document: A 'diamond' approach to personalized treatment of angina[J]. Nat Rev Cardiol, 2018, 15(2):120-132.
|
| [26] |
Pragani MA, Desai KP, Morrone D, et al. The Role of nitrates in the management of stable ischemic heart disease: a review of the current evidence and guidelines[J]. Rev Cardiovasc Med, 2017, 18(1):14-20.
|
| [27] |
Schindler TH, Dilsizian V. Coronary microvascular dysfunction: clinical considerations and noninvasive diagnosis[J]. JACC Cardiovasc Imaging, 2020, 13(1 Pt 1):140-155.
|
| [28] |
Guarini G, Huqi A, Morrone D, et al. Trimetazidine and other metabolic modifiers[J]. Eur Cardiol, 2018, 13(2):104-111.
|
| [29] |
Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease[J]. N Engl J Med, 2020, 382(15):1395-1407.
|
| [30] |
Bangalore S, Maron DJ, O'Brien SM, et al. Management of coronary disease in patients with advanced kidney disease[J]. N Engl J Med, 2020, 382(17):1608-1618.
|
| [31] |
Crea F, Bairey Merz CN, Beltrame JF, et al. Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization[J]. Eur Heart J, 2019, 40(29):2455-2462.
|
| [32] |
Dai N, Che W, Liu L, et al. Diagnostic value of angiography-derived IMR for coronary microcirculation and its prognostic implication after PCI[J]. Front Cardiovasc Med, 2021, 8:735743.
|
| [33] |
Schumann CL, Mathew RC, Dean JL, et al. Functional and economic impact of INOCA and influence of coronary microvascular dysfunction[J]. JACC Cardiovasc Imaging, 2021, 14(7):1369-1379.
|